Umbilical Cord Blood Cell Isolation via Adhesion Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and processing umbilical cord blood cells are inefficient, leading to contamination, cell yield reduction, and destruction of components, particularly affecting the isolation of endothelial cells and hematopoietic stem cells, which limits their therapeutic applications in regenerative medicine.
Innovation Solution
A method involving plating umbilical cord blood samples on a surface coated with collagen I or gelatin, allowing cell adhesion to separate endothelial cells from hematopoietic progenitor cells, with a dual vessel device for efficient cell separation and storage, preserving the viability and functionality of both cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used for isolating cells from umbilical cord blood, then the isolation process can be performed, but contamination occurs and cell yield is reduced
Solution Approach 1:
The isolation process is segmented into distinct stages: (1) density gradient centrifugation to separate mononuclear cells from other blood components, (2) adhesion-based separation where endothelial cells adhere to treated surfaces while hematopoietic stem cells remain in suspension, and (3) controlled harvesting of each cell population. This segmentation allows each step to be optimized independently, reducing contamination and minimizing cell loss.
Solution Approach 2:
A protein-coated surface (e.g., fibronectin, collagen, or gelatin-treated plastic) serves as an intermediary that selectively mediates adhesion of endothelial cells while allowing hematopoietic stem cells to remain non-adherent. This intermediary surface enables physical separation based on differential adhesion properties without requiring direct cell manipulation, thereby preserving cell viability and yield.
2Productivity
If conventional isolation methods are used, then processing can be completed, but components are destroyed and functionality is compromised
Solution Approach 1:
The plasticware and surfaces are pre-treated with extracellular matrix proteins (fibronectin, collagen, or gelatin) before cell isolation to create an adhesion-promoting environment. This preliminary action ensures that endothelial cells will selectively adhere in the subsequent steps, enabling efficient separation while maintaining cell integrity and functionality throughout the process.
Solution Approach 2:
The method exploits parameter changes in cell behavior under different cultural conditions: endothelial cells exhibit adhesion to protein-coated surfaces under static conditions, while hematopoietic stem cells remain non-adherent. By controlling parameters such as surface protein concentration, incubation time, and fluid dynamics, the method achieves selective separation that preserves the functional characteristics of both cell types.
3Adaptability or versatility
If endothelial cells are isolated from umbilical cord blood, then therapeutic applications can be enabled, but the low frequency of these cells makes isolation difficult
Solution Approach 1:
The method extracts endothelial cells from the complex umbilical cord blood matrix through a series of selective separation steps. First, density gradient centrifugation extracts mononuclear cells from whole blood. Then, adhesion-based separation extracts endothelial cells specifically from the mononuclear population by their differential adhesion to protein-coated surfaces, leaving hematopoietic stem cells in suspension. This two-stage extraction process enables efficient isolation of rare endothelial cells while preserving abundant hematopoietic stem cells for separate therapeutic applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the simultaneous isolation of endothelial and hematopoietic cells with minimal loss, maintaining the therapeutic value of umbilical cord blood, allowing for expanded use in regenerative medicine and disease prevention, while maintaining the hematopoietic stem cell functionality.
Implementation Method 1
allowing adhesion of cells in said cord blood sample to said surface, wherein said adherent cells comprise said endothelial cells
Data Source
AI summary
The invention relates to method for the separation of cord blood endothelial cells from hematopoietic cells in a manner that preserves the hematopoietic cells' repopulating ability and primitivity, without significantly reducing the yield of hematopoietic cells. The said endothelial cells from cord blood have a utility in cell based therapeutics. The system described takes advantage of the endogenous adherence properties of the cells to facilitate the separation and separate storage of the cell types.